[go: up one dir, main page]

IL137536A0 - Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations - Google Patents

Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations

Info

Publication number
IL137536A0
IL137536A0 IL13753698A IL13753698A IL137536A0 IL 137536 A0 IL137536 A0 IL 137536A0 IL 13753698 A IL13753698 A IL 13753698A IL 13753698 A IL13753698 A IL 13753698A IL 137536 A0 IL137536 A0 IL 137536A0
Authority
IL
Israel
Prior art keywords
gastroprotected
pharmaceutical preparations
obtaining same
omeprazole
omeprazole microgranules
Prior art date
Application number
IL13753698A
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL137536(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of IL137536A0 publication Critical patent/IL137536A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention concerns omeprazole microgranules each comprising an active layer containing the active principle, and an outer gastroprotecting layer containing a gastroprotecting agent, characterized in that the omeprazole is combined with at least a hydrophobic substance.
IL13753698A 1998-01-30 1998-08-10 Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations IL137536A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (en) 1998-01-30 1998-01-30 GASTROPROTEGED OMEPRAZOLE MICROGRANULES, PROCESS FOR OBTAINING AND PHARMACEUTICAL PREPARATIONS
PCT/FR1998/001783 WO1999038511A1 (en) 1998-01-30 1998-08-10 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations

Publications (1)

Publication Number Publication Date
IL137536A0 true IL137536A0 (en) 2001-07-24

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13753698A IL137536A0 (en) 1998-01-30 1998-08-10 Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations

Country Status (32)

Country Link
US (1) US6551621B1 (en)
EP (1) EP1051174B2 (en)
JP (1) JP4286452B2 (en)
KR (1) KR100510366B1 (en)
CN (1) CN1114405C (en)
AT (1) ATE232100T1 (en)
AU (1) AU755882B2 (en)
BG (1) BG65087B1 (en)
BR (1) BR9814924B1 (en)
CA (1) CA2319015C (en)
CZ (1) CZ299192B6 (en)
DE (1) DE69811278T3 (en)
DK (1) DK1051174T4 (en)
EA (1) EA002879B1 (en)
EE (1) EE05620B1 (en)
ES (1) ES2189232T5 (en)
FR (1) FR2774288B1 (en)
GE (1) GEP20032941B (en)
HK (1) HK1032354A1 (en)
HU (1) HU229956B1 (en)
IL (1) IL137536A0 (en)
IS (1) IS2866B (en)
NO (1) NO330144B1 (en)
NZ (1) NZ505998A (en)
PL (1) PL200043B1 (en)
PT (1) PT1051174E (en)
RS (1) RS50245B (en)
SI (1) SI1051174T2 (en)
SK (1) SK285666B6 (en)
TR (1) TR200002214T2 (en)
UA (1) UA61988C2 (en)
WO (1) WO1999038511A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (en) * 1999-03-12 2002-07-26 D B F GRANULES CONTAINING A PLANT SUBSTANCE AND THEIR PREPARATION METHOD
FR2793688B1 (en) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques GASTROPROTEGED MICROGRANULES, PROCESS FOR OBTAINING AND PHARMACEUTICAL PREPARATIONS
FR2845289B1 (en) * 2002-10-04 2004-12-03 Ethypharm Sa SPHEROIDS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
ES2234393B2 (en) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "FORMULATIONS OF PELETS OF ANTIULCEROSE BENCIMIDAZOLIC COMPOUNDS AND LABILS TO THE ACID".
JP2006528182A (en) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド Pharmaceutical preparations and treatment of digestive diseases caused by acids
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1648416A4 (en) * 2003-07-18 2012-03-28 Santarus Inc Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874764B (en) * 2003-10-10 2012-08-01 埃法尔姆公司 Sustained-release microgranules containing ginkgo extract and the process for manufacturing these
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007522217A (en) * 2004-02-10 2007-08-09 サンタラス インコーポレイティッド Combination of proton pump inhibitor, buffer and non-steroidal anti-inflammatory drug
MXPA06011820A (en) * 2004-04-16 2006-12-15 Santarus Inc Combination of proton pump inhibitor, buffering agent, and prokinetic agent.
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (en) * 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
LT2007362T (en) 2006-04-04 2018-11-26 Kg Acquisition Llc Oral dosage forms including an antiplatelet agent and an acid inhibitor
JP2009538901A (en) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． Dual unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
AU2007311493B2 (en) * 2006-10-17 2013-01-31 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
EA028049B1 (en) 2011-12-28 2017-10-31 Поузен Инк. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
ES2944568T3 (en) 2015-07-17 2023-06-22 Be Pharbel Mfg Multilayer microparticles for the delivery of pharmaceutically active compounds in liquid dosage form
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (en) 2018-03-08 2021-05-14 Karim Ioualalen METHOD OF FORMULATION IN THE FORM OF A HYDROPHOBIC DIVIDED SOLID

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (en) * 1988-05-18 1995-07-26 エーザイ株式会社 Oral formulation of acid labile compounds
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.
SE9302396D0 (en) * 1993-07-09 1993-07-09 Ab Astra A NOVEL COMPOUND FORM
SE9402431D0 (en) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
EP0785984B1 (en) * 1994-09-30 2002-07-10 Medical Security Corporation Method and system for cleaning and slip-resistant treatment of surface coverings
ES2094694B1 (en) † 1995-02-01 1997-12-16 Esteve Quimica Sa NEW PHARMACEUTICALLY STABLE FORMULATION OF A COMPOUND OF BENZMIDAZOLE AND ITS PROCESS OF OBTAINING.
CH687810A5 (en) 1995-05-24 1997-02-28 Mepha Ag Pellet Formulation with omeprazole.
DK1092434T3 (en) * 1995-09-21 2004-07-26 Pharma Pass Ii Llc New composition containing lansoprazole and process for its preparation
EP0941074B1 (en) * 1996-11-06 2004-07-21 Wockhardt Europe Limited Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704869D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I

Also Published As

Publication number Publication date
DK1051174T3 (en) 2003-05-26
NO20004654D0 (en) 2000-09-18
DE69811278T2 (en) 2003-11-27
CZ299192B6 (en) 2008-05-14
JP2002501895A (en) 2002-01-22
PT1051174E (en) 2003-06-30
FR2774288A1 (en) 1999-08-06
IS2866B (en) 2014-01-15
KR20010040502A (en) 2001-05-15
TR200002214T2 (en) 2000-12-21
JP4286452B2 (en) 2009-07-01
AU755882B2 (en) 2003-01-02
EA002879B1 (en) 2002-10-31
SI1051174T1 (en) 2003-06-30
FR2774288B1 (en) 2001-09-07
PL200043B1 (en) 2008-11-28
BG104634A (en) 2001-02-28
BG65087B1 (en) 2007-02-28
DK1051174T4 (en) 2012-10-01
KR100510366B1 (en) 2005-08-24
ES2189232T5 (en) 2012-11-07
HUP0100347A2 (en) 2001-10-28
AU9074898A (en) 1999-08-16
DE69811278T3 (en) 2012-11-29
CN1284877A (en) 2001-02-21
HUP0100347A3 (en) 2002-12-28
BR9814924B1 (en) 2010-07-13
EA200000797A1 (en) 2001-02-26
UA61988C2 (en) 2003-12-15
NZ505998A (en) 2003-11-28
YU48400A (en) 2003-02-28
US6551621B1 (en) 2003-04-22
WO1999038511A1 (en) 1999-08-05
PL342044A1 (en) 2001-05-21
IS5577A (en) 2000-07-25
RS50245B (en) 2009-07-15
HU229956B1 (en) 2015-03-02
EE05620B1 (en) 2013-02-15
SI1051174T2 (en) 2013-01-31
EP1051174B1 (en) 2003-02-05
CN1114405C (en) 2003-07-16
CA2319015A1 (en) 1999-08-05
EP1051174A1 (en) 2000-11-15
ES2189232T3 (en) 2003-07-01
CZ20002709A3 (en) 2000-12-13
GEP20032941B (en) 2003-04-25
SK11412000A3 (en) 2001-04-09
SK285666B6 (en) 2007-05-03
NO330144B1 (en) 2011-02-21
ATE232100T1 (en) 2003-02-15
BR9814924A (en) 2000-10-17
DE69811278D1 (en) 2003-03-13
HK1032354A1 (en) 2001-07-20
NO20004654L (en) 2000-09-18
EE200000466A (en) 2002-04-15
CA2319015C (en) 2008-08-05
EP1051174B2 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
IL137536A0 (en) Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
HK1018396A1 (en) Delivery system of an active agent.
PL327767A1 (en) Drugs containing known auxiliary substances and an active substance
HK1037974A1 (en) Pharmaceutical formulations for aerosols with two or more active substances.
HK1016886A1 (en) Drug delivery system for two or more active substances
ZA992549B (en) Incorporation of active substances in carrier matrixes.
DE69919490D1 (en) POWDER WITH FAT-SOLUBLE ACTIVE SUBSTANCE
HK1032010A1 (en) Medicament formulation with a controlled release of an active agent.
HRPK20010048B1 (en) Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
ATE187890T1 (en) LIGAND DIRECTED ENZYME PRODRUG THERAPY
HRP20020165B1 (en) Low-dose tablets and preparation method
WO1997026867A3 (en) Solid instant-release forms of administration and process for producing the same
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
AU4035399A (en) Therapeutic system for applying at least one care or active agent topically or transmucosally, on or through the nasal mucosa, and method for using the system
AU3423200A (en) Hydrophobic, rheologically active agent, method for producing the same and use thereof
ZA977873B (en) Dosage form and method for administering drug.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired